Atlas Trials

A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer

Clinical trial NCT02817425 · UNKNOWN

Trial details

NCT number
NCT02817425
Sponsor
LanZhou University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2013-05-01
Primary completion
2018-04-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.